Bausch Health Companies | VRX - Net Income

Stock Price
7.47
Daily Change
-0.02 -0.27%
Monthly
-6.27%
Yearly
14.40%
Q2 Forecast
7.31

Bausch Health Companies reported $-1.42B in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Amgen USD 1.82B 486M Mar/2026
ANI Pharmaceuticals USD 29.49M 2.86M Mar/2026
Aurora Cannabis CAD 1.82M 53.29M Dec/2025
Bausch Health Companies USD -1.42B 1.31B Mar/2026
Biogen USD 319.5M 368.4M Mar/2026
Bristol-Myers Squibb USD 2.68B 1.59B Mar/2026
Canopy Growth CAD -62.63M 60.99M Dec/2025
Corcept Therapeutics USD -31.76M 56.05M Mar/2026
Danaher USD 1.03B 168M Mar/2026
Drreddys Laboratories INR 12.1B 2.08B Dec/2025
Eli Lilly USD 7.4B 760M Mar/2026
Gilead Sciences USD 2.02B 162M Mar/2026
Nektar Therapeutics USD -36.08M 978K Dec/2025
Novo Nordisk DKK 26.89B 388M Dec/2025
Pacira USD 2.92M 1.28M Mar/2026
Perrigo USD -398.6M 1.02B Mar/2026
Phibro Animal Health USD 27.46M 932K Dec/2025
Prestige Brands USD 46.7M 22.44M Dec/2025
Supernus Pharmaceuticals USD -2.29M 1.81M Mar/2026
Vertex Pharmaceuticals USD 1.03B 159.7M Mar/2026
Zoetis USD 601M 2M Mar/2026